PT Tempo Scan Pacific (TSP), formerly known as PT Scanchemie, was founded in May 1970 by PT Perusahaan Dagang Tempo (Tempo) and PT Indonesian Pharmaceutical Industries. After a reorganization which was completed in 1993, PT Bogamulia Nagadi became the majority shareholder of the company. PT Bogamulia Nagadi is the holding company of the present Tempo Group.
TSP initially acted as a contract manufacturer of over-the-counter (OTC) medicine for PT Tempo. Since 1980, its business has broadened to include the manufacturing and marketing of a diverse range of well-known ethical and OTC pharmaceutical products under license as well as its own-developed brands. Following a corporate restructuring exercise which began in 1991 and was completed in 1993, TSP, a Good Manufacturing Practise (GMP) certified pharmaceutical manufacturer, acquired its present name.
OTC pharmaceutical products make up the bulk of TSPs pharmaceutical revenue, with major products being Bodrex, Bodrexin and Hemaviton. Bodrex, and Bodrexin, respectively, commanded an estimated 22% and 16% of the analgesic and pediatric analgesic markets since 1993, while Hemaviton held an estimated 40% of the multivitamin market share. In addition, TSP produces Neo Rheumacyl which has an estimated 20% market share in the anti-rheumatism drugs sector.
